Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.
Toback, S; Galiza, E; Cosgrove, C; Galloway, J; Goodman, AL; Swift, PA; Rajaram, S; Graves-Jones, A; Edelman, J; Burns, F; Minassian, AM; Cho, I; Kumar, L; Plested, JS; Rivers, EJ; Robertson, A; Dubovsky, F; Glenn, G; Heath, PT; 2019nCoV-302 Study Group,;
2021
The Lancet. Respiratory medicine, (2021).10 2 10.1016/s2213-2600(21)00409-4.
Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis.
Chmielewska, B; Barratt, I; Townsend, R; Kalafat, E; VAN DER MEULEN, J; GUROL-URGANCI, I; O'Brien, P; Morris, E; Draycott, T; Thangaratinam, S; Le Doare, K; Ladhani, S; Von Dadelszen, P; Magee, L; Khalil, A;
2021
The Lancet. Global health, (2021).9 6 10.1016/S2214-109X(21)00079-6.
Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials.
Pepperrell, T; Rodgers, F; Tandon, P; Sarsfield, K; Pugh-Jones, M; Rashid, T; KEESTRA, S;
2021
Glob Health Action, (2021).14 1 10.1080/16549716.2021.1892309.
An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: national validation cohort study in England.
NAFILYAN, V; Humberstone, B; Mehta, N; Diamond, I; Coupland, C; Lorenzi, L; Pawelek, P; Schofield, R; Morgan, J; Brown, P; Lyons, R; Sheikh, A; Hippisley-Cox, J;
2021
Cold Spring Harbor Laboratory (2021). 10.1101/2021.01.22.21249968.
Free licensing of vaccines to end the COVID-19 crisis.
Bozorgmehr, K; Jahn, R; Stuckler, D; MCKEE, M;
2021
Lancet (London, England), (2021).397 10281 10.1016/S0140-6736(21)00467-0.
SARS-CoV-2 variants, spike mutations and immune escape.
Harvey, WT; Carabelli, AM; Jackson, B; Gupta, RK; THOMSON, EC; Harrison, EM; Ludden, C; Reeve, R; Rambaut, A; COVID-19 Genomics UK (COG-UK) Consortium,; Peacock, SJ; Robertson, DL;
2021
Nature reviews. Microbiology, (2021).19 7 10.1038/s41579-021-00573-0.
Economic and social impacts of COVID-19 and public health measures: results from an anonymous online survey in Thailand, Malaysia, the UK, Italy and Slovenia.
Osterrieder, A; Cuman, G; Pan-Ngum, W; Cheah, PK; Cheah, P-K; Peerawaranun, P; Silan, M; Orazem, M; Perkovic, K; Groselj, U; Schneiders, ML; Poomchaichote, T; Waithira, N; Asarath, S-A; Naemiratch, B; Ruangkajorn, S; Skof, L; Kulpijit, N; MACKWORTH-YOUNG, CR S; Ongkili, D; Chanviriyavuth, R; Mukaka, M; Cheah, PY;
2021
BMJ open, (2021).11 7 10.1136/bmjopen-2020-046863.
The SARS-CoV-2 Alpha variant is associated with increased clinical severity of COVID-19 in Scotland: a genomics-based retrospective cohort analysis.
Pascall, D; Vink, E; Blacow, R; Bulteel, N; Campbell, A; Campbell, R; Clifford, S; Davis, C; Da Silva Filipe, A; Sakka, NE; Fjodorova, L; Forrest, R; Goldstein, E; Gunson, R; Haughney, J; Holden, MT G; Honour, P; Hughes, J; James, E; Lewis, T; Lycett, S; MacLean, O; McHugh, M; Mollett, G; Onishi, Y; ... The COVID-19 Genomics UK (COG-UK) consortium,
2021
medRxiv (2021). 10.1101/2021.08.17.21260128.
Precautionary Breaks: Planned, Limited Duration Circuit Breaks to Control the Prevalence of COVID-19.
Keeling, M; Guyver-Fletcher, G; Holmes, A; Dyson, L; Tildesley, M; Hill, E; MEDLEY, G;
2020
SSRN (2020). 10.2139/ssrn.3725627.
The COVID-19 vaccines rush: participatory community engagement matters more than ever.
Burgess, RA; Osborne, RH; Yongabi, KA; Greenhalgh, T; Gurdasani, D; Kang, G; Falade, AG; Odone, A; Busse, R; Martin-Moreno, JM; Reicher, S; MCKEE, M;
2020
LANCET, (2020).397 10268 10.1016/S0140-6736(20)32642-8.